Literature DB >> 11118161

Screening for familial hypercholesterolaemia. Effective, safe treatments and dna testing make screening attractive.

J J Kastelein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11118161      PMCID： PMC1119204          DOI： 10.1136/bmj.321.7275.1483

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study.

Authors:  H A Neil; T Hammond; R Huxley; D R Matthews; S E Humphries
Journal:  BMJ       Date:  2000-07-15

2.  [Higher prevalence of familial hypercholesterolemia than expected in adult patients of four family practices in Netherlands].

Authors:  P J Lansberg; S Tuzgöl; M A van de Ree; J C Defesche; J J Kastelein
Journal:  Ned Tijdschr Geneeskd       Date:  2000-07-22

3.  Psychosocial function during treatment for familial hypercholesterolemia.

Authors:  S Tonstad; T S Nøvik; I H Vandvik
Journal:  Pediatrics       Date:  1996-08       Impact factor: 7.124

4.  Patients' attitudes toward detection of heterozygous familial hypercholesterolemia.

Authors:  L K Andersen; H K Jensen; S Juul; O Faergeman
Journal:  Arch Intern Med       Date:  1997-03-10

5.  Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia.

Authors:  D Bhatnagar; J Morgan; S Siddiq; M I Mackness; J P Miller; P N Durrington
Journal:  BMJ       Date:  2000-12-16

6.  Familial hypercholesterolaemia: a pilot study of parents' and children's concerns.

Authors:  S Tonstad
Journal:  Acta Paediatr       Date:  1996-11       Impact factor: 2.299

7.  Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.

Authors: 
Journal:  BMJ       Date:  1991-10-12

8.  Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.

Authors: 
Journal:  Atherosclerosis       Date:  1999-01       Impact factor: 5.162

9.  Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia.

Authors:  M J Mol; D W Erkelens; J A Leuven; J A Schouten; A F Stalenhoef
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321
  9 in total
  4 in total

Review 1.  Genetic risk and behavioural change.

Authors:  T M Marteau; C Lerman
Journal:  BMJ       Date:  2001-04-28

Review 2.  Cardiovascular genetic medicine: the genetics of coronary heart disease.

Authors:  David Seo; Pascal J Goldschmidt-Clermont
Journal:  J Cardiovasc Transl Res       Date:  2008-05-23       Impact factor: 4.132

Review 3.  Optimal management of familial hypercholesterolemia: treatment and management strategies.

Authors:  Mohammad Hassan Nemati; Behrooz Astaneh
Journal:  Vasc Health Risk Manag       Date:  2010-12-03

4.  Simultaneous detection of multiple familial hypercholesterolemia mutations facilitates an improved diagnostic service in South african patients at high risk of cardiovascular disease.

Authors:  Maritha J Kotze; Gernot Kriegshäuser; Rochelle Thiart; Nico J P de Villiers; Charlotte L Scholtz; Fritz Kury; Anne Moritz; Christian Oberkanins
Journal:  Mol Diagn       Date:  2003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.